Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

European approvals for RPR's Nasacort AQ

Nov. 28, 1997

Bronchodilating mechanism of PDE IV inhibitors investigated using CP-80633

Nov. 27, 1997

Ono's elastase inhibitor poised to enter phase I in Europe

Nov. 27, 1997

Fujirebio, Nippon Chemiphar to codevelop antiasthma drug

Nov. 26, 1997

Arzneimittelwerk Dresden prepares new 5-LO inhibitors

Nov. 26, 1997

Dual CysLT1/H1 receptor antagonists described in patent literature

Nov. 25, 1997

New NK1 antagonist from Novartis

Nov. 24, 1997

Accolate now available in Canada

Nov. 21, 1997

RPR redirects development of PDE IV inhibitor

Nov. 21, 1997

New NK3/NK4 antagonist in the pipeline at SKB

Nov. 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...